Orthopedic Biomaterial Market to Reach USD 29.62 Billion and Growing at a CAGR of 9.4% in 2028 | Regional Analysis|
Orthopedic Biomaterial Market Forecast
The orthopedic
biomaterials market is expected to register a CAGR of 10. 5% during the
assessment period of 2020 to 2027, to reach USD 40,519.52 million by 2027.
Market Overview:
Orthopedic
biomaterials are implanted in the human body as constituents. These devices are
designed to perform certain biological functions by substituting or repairing
different tissues such as bone, cartilage, or ligaments and tendons and even
guiding bone repair when necessary.
The growth of the
orthopedic biomaterials market is driven by factors such as the growing demand
for next-generation orthopedic biomaterials and the increasing prevalence of
orthopedic diseases. In addition, the increasing prevalence of chronic diseases
creates a lucrative opportunity for the market. However, lack of reimbursement
and an ambiguous regulatory framework is likely to restrain the market growth.
COVID-19 Analysis:
The pandemic is
likely to have devastating effects on the global economy, more intense than the
global financial crisis during 2008-2009. It is affecting the demand and supply
chain, which will severely hurt global trade. The top players in the market are
expected to continue to fulfill the current demand for orthopedic biomaterials,
including reconstructive joint replacements and spinal implants. Furthermore,
various governments across the world are encouraging the key players to improve
the current manufacturing facilities. However, with the decline in elective
surgical procedures, the orthopedic biomaterials market is expected to witness
a slump in 2020.
List of Key
Companies Covered in this Report:
1.
Stryker (US)
2.
CoorsTek Inc. (US)
3.
Zimmer Biomet Holdings Inc. (US)
4.
Institut Straumann AG (Switzerland)
5.
Kyocera Corporation (Japan)
6.
Smith & Nephew plc (UK)
7.
3M (US)
8.
Nobel Biocare Services AG(Switzerland)
9.
Medtronicplc (Ireland)
10.
DePuy Synthes (US)
Market Dynamics:
Increasing older population leading to an increase in the patient
population
Geriatric individuals are more
susceptible to orthopedic diseases. Thus, the growing geriatric population is
likely to increase the demand for orthopedic biomaterials. According to the
Office for National Statistics, in 2017, ~18% and 2.4% of the total UK
population was aged over 65 years and 85 years, respectively. With the high
incidence of joint replacement procedures, over 1 million hip and total knee
replacement procedures are performed each year in the US. This huge number of
joint and knee replacements is increasing the demand for orthopedic
biomaterial. Therefore, the growing elderly population is anticipated to boost
the growth of the global orthopedic
biomaterials market over the assessment period.
Growing demand for next-generation orthopedic biomaterials
Restraints
Lack of reimbursements
Limited
reimbursement coverage options are present for these products. The
reimbursement for orthopedic biomaterials is also declining in various
countries, which has impeded market growth. This lack of reimbursements has put
pressure on manufacturers to lower the prices for these materials. All these
factors have restricted the growth of the market.
Opportunities
Technological advancement in the medical implants market
Nowadays, consumers
are becoming more conscious and aware of the issues related to health. Thus,
companies are focusing more on research & development to introduce better
technology and treatment, which gives them an edge over their competitors.
Companies are looking forward to introducing innovative technologies.
Currently, several devices are present in the market for various medical
conditions. Players focus on the development of technologically advanced
products. For instance, in September 2019, Zimmer Biomet Holdings, Inc., a
US-based healthcare solutions provider, announced FDA 510(k) clearance for the
Persona Revision Knee System for revision knee replacement procedures. It
offers components designed to match a patient's anatomy for a personalized fit.
Value Chain Analysis
The global
orthopedic biomaterials market is growing steadily due to the rising incidence
of orthopedic injury and growing demand for next-generation orthopedic
biomaterial. So,with the rising use of orthopedic biomaterial, many players are
showing keen interest in launching new products. The value chain analysis of
the orthopedic biomaterials market comprises four major components: the
software development process and designing, followed by R&D and designing,
manufacturing, distribution, marketing,and sales with post-selling services.
Segment Overview:
By Product
Reconstructive
Joint Replacements:
Reconstructive
joint replacement is a medical procedure that includes the replacement of the
damaged joint. It includes minor repair to total joint replacement and offers
pain relief as well as permanent solutions to joint disorders. Reconstructive
joint replacements include various types of implants, such as knee replacement
implants, hip replacement implants, and others. According to the American
Academy of Orthopedic Surgeons (AAOS), around 1.6 million hip and knee
surgeries and 966,000 knee replacements were performed in the US in 2017.
The market growth
of this segment is attributed to the increasing geriatric population and rising
cases of orthopedic surgery. Moreover, there has been a strong focus on
improving healthcare services globally, which further boosts the market's
growth.
Spinal Implants:
A spinal implant is
a type of medical device used in the management of spine disorders. Spinal
implants consist of polyetheretherketone (PEEK) and titanium alloys. Cobalt
chromium alloys are used in disc replacements type of spinal implants. As per
the North American Spine Society, around 1.4 million spinal procedures were
performed each year in the US. The largest number of procedures were performed
in cervical repair, with over 350,000 total procedures.
Dental Implants:
Dental implants are
a type of surgical component that edges with the jaw's bone to support dental
prostheses like crowns, dentures, and facial prostheses. Moreover, the modern
dental implant is a biological process also known as osseointegration, in which
titanium material is used to form a close bond to the bone. Dental implants
have two types such as root-form dental implants and plate-form dental implants.
Trauma:
Trauma is a
critical injury to the bones, joints, ligaments, muscles, and soft tissue
caused by accident and fall. As per the World Health Organization, prevalence
of trauma orthopedic injury is around 63.6%.
Orthobiologics:
Orthobiologics are
biological substances used to provide relief in musculoskeletal
injuries.Orthobiologics are various types such as viscosupplementation,
demineralized bone matrix, synthetic bone substitutes, bone morphogenetic
proteins, and allograft.
Free Sample Report @ https://www.marketresearchfuture.com/reports/orthopedic-biomaterial-market-415
Regional Analysis
Americas:
The Americas
dominated the orthopedic
biomaterials market in 2019 and is likely to continue during the assessment
period as well. This can be attributed to the high prevalence of orthopedic
diseases, product launches, and technological advancement in this region. The
high demand for orthopedic biomaterials and the adequate availability of
skilled professionals in the region are expected to fuel the regional market
growth. The growing elderly population is also resulting in the growth of the
orthopedicbiomaterials market in the Americas. As per the Administration for
Community Living, in the Americas, over the last ten years, the population aged
65 and over grew from 37.2 million in 2006 to 49.2 million in 2016.
Europe:
Europe held the
second-largest position in the orthopedic biomaterials market in 2019 and is
anticipated to witness significant growth over the forecast period due to a
higher number of patients and the availability of products in the region. In
2017, Switzerland, Finland, Luxembourg, Germany, Austria, and Belgium were
among the countries with the highest number of hip and knee replacements in the
region. The OECD averages are 182 per 100,000 population for hip replacements
and 135 per 100,000 for knee replacements. On average, hip replacement rates increased
by 30% between 2007 and 2017, and knee replacement rates increased by 40% in
the same period. This increase in patients undergoing knee and replacement is
anticipated to boost the regional market's growth.
Asia-Pacific:
The Asia-Pacific is
anticipated to register the highest growth rate duringthe forecast period.
According to the United Nations, across Asia, the number of people aged 65 and
above is expected to grow dramatically over the next 50 years. For the region,
the population in this age group will increase by 31.4%, from 207 million in
2000 to 857 million in 2050. A large number of adults residing in the region
are expected to suffer from various orthopedic disorders. This is expected to
drive the growth of the regional orthopedic biomaterials market during the
study period.
Middle East &
Africa:
The orthopedic
biomaterials market in the Middle East & Africa has been growing steadily
in recent years. The key factors propelling the growth of the regional market
are the increasing the prevalence of orthopedics disorders and funding by
private players and government bodies.
Competitive Landscape
The global
orthopedic biomaterials market is characterized by the presence of many global,
regional, and local vendors catering to the demand created by a large patient
pool in need of diagnostic and surgical services. The availability of
innovative products is increasing the lucrativeness of the global orthopedic
biomaterials market. The key players have adopted the strategy of signing
contracts and agreements to expand their global presence and optimize
operational costs.
The market is
highly competitive, with players competing and partnering to gain a substantial
market share. The global orthopedic biomaterials market is moderately
consolidated with rising competition, product launches, rising collaborative
partnerships, and other strategic decisions to achieve operational efficiency.
The vendors compete based on cost, quality, timely availability, and
reliability of products offered. It is decisive for the players operating in
the orthopedic biomaterials market to provide cost-efficient products to
survive and succeed in an increasingly competitive and growing market
environment.
NOTE: Our Team of
Researchers are Studying Covid19 and its Impact on Various Industry Verticals
and wherever required we will be considering Covid19 Footprints for Better
Analysis of Market and Industries. Cordially get in Touch for More Details.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited), 99 Hudson
Street,5Th Floor, New York, New York 10013, United States of America
Comments
Post a Comment